A groundbreaking immunotherapy has been registered in South Africa for recurrent or metastatic nasopharyngeal carcinoma, a rare and aggressive cancer.

Dr Reddy’s Laboratories introduces innovative immunotherapy in South Africa for treating rare head and neck cancer, enhancing patient care.

A groundbreaking immunotherapy has been registered in South Africa for recurrent or metastatic nasopharyngeal carcinoma, a rare and aggressive cancer.